Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Recruiting
Early Phase 1
Interventional Study
Breast Cancer
Lymphoma
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 104 (estimated)
- Sponsor
- University of Oklahoma · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is to determine if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain chemical markers of inflammation in study participants' blood.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients (\>18 years) who have received anthracycline-based therapy for breast cancer or lymphoma within the last 30 days
* A least 1 of following additional criteria:
* previous chest radiation
. Age\>50
* type 2 diabetes mellitus
* hypertension
* current smokin…
Contacts